Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Tecan U.S. Compliance Difficulties Dampen North American Q3 Sales

This article was originally published in The Gray Sheet

Executive Summary

Tecan is taking steps to bolster its regulatory processes, following compliance problems that emerged during an FDA inspection of the firm's Durham, N.C. facility

You may also be interested in...



Wrist Device, Medical Software Web Claims Draw Warning Letters

Carpal Kinetics' Wristrac for treatment of Carpal Tunnel Syndrome requires a 510(k) because the device differs from other nonpowered orthopedic traction devices, FDA informs the firm in a warning letter released Oct. 26

Wrist Device, Medical Software Web Claims Draw Warning Letters

Carpal Kinetics' Wristrac for treatment of Carpal Tunnel Syndrome requires a 510(k) because the device differs from other nonpowered orthopedic traction devices, FDA informs the firm in a warning letter released Oct. 26

Roche Readies Tecan Clinical Workstation 510(k) After Warning Letter

Roche Diagnostics is preparing to submit a 510(k) for the Tecan clinical workstation, following receipt of a related 1warning letter

UsernamePublicRestriction

Register

LL1134882

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel